155 related articles for article (PubMed ID: 23575450)
1. Preventive effect of ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patients.
Zhang L; Wang N; Zhou S; Ye W; Yao Q; Jing G; Zhang M
World J Surg Oncol; 2013 Apr; 11():84. PubMed ID: 23575450
[TBL] [Abstract][Full Text] [Related]
2. Influence of a human protease inhibitor on surgical stress induced immunosuppression.
Sato N; Endo S; Kimura Y; Ikeda K; Aoki K; Iwaya T; Akiyama Y; Noda Y; Saito K
Dig Surg; 2002; 19(4):300-5. PubMed ID: 12207074
[TBL] [Abstract][Full Text] [Related]
3. [Effect of ulinastatin on inflammatory responses induced by oesophagectomy].
Lu XY; Zeng WA; Lin WQ; Chen BX; He WX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):81-3. PubMed ID: 17259154
[TBL] [Abstract][Full Text] [Related]
4. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.
Nishi T; Takeuchi H; Matsuda S; Ogura M; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
World J Surg Oncol; 2015 Aug; 13():232. PubMed ID: 26231560
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of high-dose ulinastatin during surgery does not improve early postoperative clinical outcomes in patients undergoing radical lung cancer surgery: A pilot study.
Zhou L; Lan H; Zhou Q; Tang XJ; Zhu D; Yue J; Liu B
Thorac Cancer; 2016 Sep; 7(5):581-587. PubMed ID: 27766771
[TBL] [Abstract][Full Text] [Related]
6. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
[TBL] [Abstract][Full Text] [Related]
7. [Case-control study on the effect of ulinastatin on postoperative complications in elderly patients undergoing hip joint replacement].
Ge YY; Xu Y; Cheng JQ; Chen JM; Xu RM; Jiang YD
Zhongguo Gu Shang; 2011 Jun; 24(6):459-62. PubMed ID: 21786544
[TBL] [Abstract][Full Text] [Related]
8. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
9. Lack of Lymphocyte Recovery After Esophagectomy Predicts Overall and Recurrence-Free Survival.
Hall BM; Geraci TC; Machan JT; Milman S; Adams CA; Cioffi W; Ng T; Monaghan S
J Surg Res; 2020 Feb; 246():379-383. PubMed ID: 31676146
[TBL] [Abstract][Full Text] [Related]
10. Effects of ulinastatin on early postoperative cognitive function after one-lung ventilation surgery in elderly patients receiving neoadjuvant chemotherapy.
Wang KY; Yang QY; Tang P; Li HX; Zhao HW; Ren XB
Metab Brain Dis; 2017 Apr; 32(2):427-435. PubMed ID: 27830357
[TBL] [Abstract][Full Text] [Related]
11. Impact of postoperative complications on long-term survival after esophagectomy in older adults: A SEER-Medicare analysis.
Sesti J; Almaz B; Bell J; Nguyen A; Bamboat Z; Lackey A; Langan RC; Turner AL; Hilden P; Paul S
J Surg Oncol; 2021 Oct; 124(5):751-766. PubMed ID: 34223641
[TBL] [Abstract][Full Text] [Related]
12. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence.
Lagarde SM; de Boer JD; ten Kate FJ; Busch OR; Obertop H; van Lanschot JJ
Ann Surg; 2008 Jan; 247(1):71-6. PubMed ID: 18156925
[TBL] [Abstract][Full Text] [Related]
13. Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer.
Nakashima Y; Saeki H; Hu Q; Tsuda Y; Zaitsu Y; Hisamatsu Y; Ando K; Kimura Y; Oki E; Mori M
Ann Surg Oncol; 2020 Feb; 27(2):492-498. PubMed ID: 31549319
[TBL] [Abstract][Full Text] [Related]
14. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial).
van der Sluis PC; Ruurda JP; van der Horst S; Verhage RJ; Besselink MG; Prins MJ; Haverkamp L; Schippers C; Rinkes IH; Joore HC; Ten Kate FJ; Koffijberg H; Kroese CC; van Leeuwen MS; Lolkema MP; Reerink O; Schipper ME; Steenhagen E; Vleggaar FP; Voest EE; Siersema PD; van Hillegersberg R
Trials; 2012 Nov; 13():230. PubMed ID: 23199187
[TBL] [Abstract][Full Text] [Related]
15. Ulinastatin, a protease inhibitor, may inhibit allogeneic blood transfusion-associated pro-inflammatory cytokines and systemic inflammatory response syndrome and improve postoperative recovery.
Shu H; Liu K; He Q; Zhong F; Yang L; Li Q; Liu W; Ye F; Huang W
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s109-18. PubMed ID: 23736923
[TBL] [Abstract][Full Text] [Related]
16. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
[TBL] [Abstract][Full Text] [Related]
17. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.
Schwameis K; Ba-Ssalamah A; Wrba F; Birner P; Prager G; Hejna M; Schmid R; Asari R; Zacherl J; Schoppmann SF
Anticancer Res; 2013 May; 33(5):2085-91. PubMed ID: 23645759
[TBL] [Abstract][Full Text] [Related]
18. Cancer Recurrence After Esophagectomy: Impact of Postoperative Infection in Propensity-Matched Cohorts.
Tam V; Luketich JD; Winger DG; Sarkaria IS; Levy RM; Christie NA; Awais O; Shende MR; Nason KS
Ann Thorac Surg; 2016 Nov; 102(5):1638-1646. PubMed ID: 27353482
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Outcome of Esophagectomy Versus Nonsurgical Treatment for Resectable Esophageal Cancer with Clinical Complete Response to Neoadjuvant Therapy.
Ohkura Y; Shindoh J; Ueno M; Iizuka T; Udagawa H
Ann Surg Oncol; 2018 Aug; 25(8):2428-2433. PubMed ID: 29564587
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
